Clinical trials
Mosaicism clinical trials
Below are recruiting mosaicism clinical trials, each written for real people, not researchers. We’re tracking 14 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT04472156Recruiting
Testing one embryo transfer after mosaic PGT results
This study follows people who have infertility and, after IVF testing (PGT), have a “mosaic” embryo result. It looks at transferring one embryo to see how this approach works when mosaic changes are present.
Lone Tree, ColoradoAges 18–45 - NCT04109846Recruiting
Embryo transfer using aneuploid or mosaic embryos during pregnancy
This trial looks at pregnancy and baby outcomes when embryos that have chromosome differences (aneuploidy or mosaic embryos) are transferred, especially when no other embryos are available. It may help people understand the risks and expected outcomes in situations where options are limited.
Sunnyvale, CaliforniaAges 18–55 - NCT07683104Recruiting
How trisomy 8 autoinflammatory disease progresses over time
This study follows people who have trisomy 8 (an extra copy of a chromosome) that causes inflammation and mouth/genital ulcers, and their family members. Researchers want to learn how this condition changes over time, so they can better understand and treat it.
Bethesda, MarylandAges 1 day–99 years - NCT07710443Recruiting
Mosaic Filler Trial for Midface Volume Loss
This trial tests a new cheek filler called Mosaic for people with moderate to severe cheek volume loss. It helps doctors see if Mosaic is safe and effective for filling out the midface area.
Bradenton, FloridaAges 22 years+ - NCT06863142RecruitingPhase 1
Testing a new flu vaccine with or without adjuvant
This study tests a new investigational flu vaccine (FluMos-v2) with or without an adjuvant (ALFQ) to see how safe, tolerable, and effective it is. It may help protect against multiple flu strains.
Bethesda, MarylandAges 18–50 - NCT07036536Recruiting
Non-Euploid Embryo Transfer Registry
This registry is collecting information from people who plan to transfer an embryo that is not genetically normal (non-euploid) at a fertility clinic in The Prelude Network. It will help doctors learn more about outcomes with these embryos.
Houston, TexasAges Any age - NCT03396562Recruiting
Study of early development in babies with extra sex chromosomes
This study follows infants and young children with conditions caused by having an extra sex chromosome (like XXY, XYY, or XXX) to learn how health and development unfold over time. It may help families and doctors understand what to expect and what support could be helpful.
Aurora, ColoradoAges 1 month–1.1 years - NCT04385290RecruitingPhase 1/Phase 2
Testing midostaurin plus gemtuzumab for newly diagnosed AML
This trial studies whether combining two medicines—midostaurin and gemtuzumab (with standard chemotherapy)—can improve outcomes for newly diagnosed acute myeloid leukemia (AML). It is testing a first-line treatment plan tailored to specific genetic changes in the leukemia.
München, BavariaAges 18–75 - NCT04541654Recruiting
Study of families with TP53 gene changes in Li-Fraumeni syndrome
This study is looking at how people in families with certain TP53 gene changes (including Li-Fraumeni syndrome) develop health problems over time. It may help doctors better understand risk and improve care for affected families.
Boston, MassachusettsAges Any age - NCT06053671Recruiting
Understanding genetics in focal epilepsy brain tissue
This study is looking at brain tissue from people with a specific type of epilepsy (Focal Cortical Dysplasia Type II). The goal is to understand what causes the seizures and how they develop, which may help improve future treatments.
LondonAges Any age - NCT06054295Recruiting
Twin study of childhood brain tumors
This study looks at genetic differences between identical twins where only one twin has a childhood brain or spinal cord tumor. It helps researchers understand why some children get cancer and others don't.
Minneapolis, MinnesotaAges Up to 18 years - NCT06917586Recruiting
Mosaic mitral valve study for patients under 65
This study looks at long-term results in people under 65 who received a specific type of replacement heart valve (the Mosaic mitral valve) during surgery at ProMedica Toledo Hospital. It aims to understand how well the valve works over time.
Toledo, OhioAges 18–65 - NCT06960993Recruiting
Mosaic trial for stem cell transplant patients
This trial tests a website designed to help patients learn about stem cell transplants for blood cancers. It aims to support you during your transplant journey.
Washington D.C., District of ColumbiaAges 18 years+ - NCT06828549Enrolling by invitation
Mobile support for diabetes tailored to your needs
This study tests a mobile health program designed to help people with type 2 diabetes manage their condition better. You and a support person (like a family member or friend) will use your phones to get reminders, tips, and encouragement.
Birmingham, AlabamaAges 18–75
Hear when a new Mosaicism trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for mosaicism?
- Yes. Clin2 currently lists 14 recruiting mosaicism studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a mosaicism trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a mosaicism trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.